speb/financial-data huggingface dataset:
Financial ratios for BF.A — quarterly report dated 2025-01-31
Total revenue: 1348000000
Gross profit: 619000000
Operating income: 311000000
Net income: 270000000
Capital expenditures: 6000000
Operating cash flow: 317000000
Depreciation & amortization: 22000000
Net tangible assets: 1415000000
Owner earnings: 286000000
Return on net tangible assets (%): 20.21201413427562
Capex to operating income (%): 1.929260450160772
Buffett classification: The Great
Stock price: 31.77
P/E ratio: 4.95614497475
Shares outstanding: 168480849
Book value: 3823000000
P/B ratio: 1.4001141963719592
Market cap (USD): 5352636572.73
Debt to equity: 0.7488883076118231
Current ratio: 3.4873675631621843
Quick ratio: 1.4898125509372453
Effective tax rate (%): 18.67469879518072
Interest coverage ratio: 10.03225806451613
COGS to revenue (%): 30.86053412462908
SG&A to revenue (%): 22.47774480712166
Free cash flow (dilution-adjusted): 265000000
Buyback yield (%): 0
Retained earnings: 4671000000
Inventory turnover: 0.1697266421868625
Receivables turnover: 1.576608187134503
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.544126241963764
FCF margin (%): 19.658753709198812
Rule of 40 score: 19.658753709198812
Financial ratios for BF.A — quarterly report dated 2025-04-30
Total revenue: 1121000000
Gross profit: 513000000
Operating income: 232000000
Net income: 146000000
Capital expenditures: 50000000
Operating cash flow: 152000000
Depreciation & amortization: 21000000
Net tangible assets: 1507000000
Owner earnings: 117000000
Return on net tangible assets (%): 7.76376907763769
Capex to operating income (%): 21.551724137931032
Buffett classification: The Great
Stock price: 33.21
P/E ratio: 9.580905813852741
Shares outstanding: 168480849
Book value: 3993000000
P/B ratio: 1.4012644616303531
Market cap (USD): 5595248995.29
Debt to equity: 0.6844477836213373
Current ratio: 3.884259259259259
Quick ratio: 1.5592592592592593
Effective tax rate (%): 20.21857923497268
Interest coverage ratio: 8.592592592592593
COGS to revenue (%): 33.98751115075825
SG&A to revenue (%): 26.761819803746654
Free cash flow (dilution-adjusted): 94000000
Buyback yield (%): 0
Retained earnings: 4710000000
Inventory turnover: 0.15173237753882915
Receivables turnover: 1.3506024096385543
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.311447330859264
FCF margin (%): 8.385370205173952
Revenue growth (%): -16.839762611275965
Rule of 40 score: -8.454392406102013
Financial ratios for BF.A — annual report dated 2025-04-30
Total revenue: 5056000000
Gross profit: 2343000000
Operating income: 1214000000
Net income: 869000000
Capital expenditures: 116000000
Operating cash flow: 598000000
Depreciation & amortization: 87000000
Net tangible assets: 1507000000
Owner earnings: 840000000
Return on net tangible assets (%): 55.739880557398806
Capex to operating income (%): 9.555189456342669
Buffett classification: The Great
Stock price: 33.21
P/E ratio: 6.4387215135673195
Shares outstanding: 168480849
Book value: 3993000000
P/B ratio: 1.4012644616303531
Market cap (USD): 5595248995.29
Debt to equity: 0.6844477836213373
Current ratio: 3.884259259259259
Quick ratio: 1.5592592592592593
Effective tax rate (%): 19.611470860314522
Interest coverage ratio: 9.950819672131148
COGS to revenue (%): 32.278481012658226
SG&A to revenue (%): 24.287974683544302
Free cash flow (dilution-adjusted): 403000000
Buyback yield (%): 0
Retained earnings: 4710000000
Inventory turnover: 0.6499402628434886
Receivables turnover: 6.091566265060241
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.32800456751356
FCF margin (%): 7.970727848101265
Revenue growth (%): -5.105105105105105
Rule of 40 score: 2.86562274299616
Financial ratios for BF.A — quarterly report dated 2025-07-31
Total revenue: 1191000000
Gross profit: 552000000
Operating income: 272000000
Net income: 170000000
Capital expenditures: 31000000
Operating cash flow: 160000000
Depreciation & amortization: 22000000
Net tangible assets: 1410000000
Owner earnings: 161000000
Return on net tangible assets (%): 11.418439716312056
Capex to operating income (%): 11.397058823529411
Buffett classification: The Great
Stock price: 27.71
P/E ratio: 7.966901579846417
Shares outstanding: 168480849
Book value: 3988000000
P/B ratio: 1.1706630706594785
Market cap (USD): 4668604325.79
Debt to equity: 0.6772818455366099
Current ratio: 2.790915163660655
Quick ratio: 1.0634602538410154
Effective tax rate (%): 22.727272727272727
Interest coverage ratio: 10.88
COGS to revenue (%): 31.234256926952142
SG&A to revenue (%): 24.937027707808564
Free cash flow (dilution-adjusted): 125000000
Buyback yield (%): 0
Retained earnings: 4666000000
Inventory turnover: 0.14385150812064965
Receivables turnover: 1.4061393152302244
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.075516931375487
FCF margin (%): 10.495382031905962
Revenue growth (%): 6.244424620874219
Rule of 40 score: 16.73980665278018
Financial ratios for BF.A — quarterly report dated 2025-10-31
Total revenue: 1336000000
Gross profit: 615000000
Operating income: 309000000
Net income: 224000000
Capital expenditures: 25000000
Operating cash flow: 132000000
Depreciation & amortization: 22000000
Net tangible assets: 1549000000
Owner earnings: 221000000
Return on net tangible assets (%): 14.267269205939314
Capex to operating income (%): 8.090614886731391
Buffett classification: The Great
Stock price: 26.44
P/E ratio: 5.499547713037037
Shares outstanding: 168480849
Book value: 4134000000
P/B ratio: 1.0775601469666185
Market cap (USD): 4454633647.56
Debt to equity: 0.6402999516207063
Current ratio: 2.973870056497175
Quick ratio: 1.1666666666666667
Effective tax rate (%): 19.71326164874552
Interest coverage ratio: 11.884615384615385
COGS to revenue (%): 31.511976047904195
SG&A to revenue (%): 23.42814371257485
Free cash flow (dilution-adjusted): 99000000
Buyback yield (%): 0
Retained earnings: 4890000000
Inventory turnover: 0.16451738960531456
Receivables turnover: 1.2821497120921306
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.5407788390889054
FCF margin (%): 7.410179640718563
Revenue growth (%): 12.174643157010916
Rule of 40 score: 19.58482279772948
Financial ratios for BF.A — quarterly report dated 2026-01-31
Total revenue: 1396000000
Gross profit: 640000000
Operating income: 343000000
Net income: 267000000
Capital expenditures: 8000000
Operating cash flow: 417000000
Depreciation & amortization: 24000000
Net tangible assets: 1458000000
Owner earnings: 283000000
Return on net tangible assets (%): 19.410150891632373
Capex to operating income (%): 2.3323615160349855
Buffett classification: The Great
Stock price: 27.35
P/E ratio: 5.709976728810409
Shares outstanding: 168480849
Book value: 4082000000
P/B ratio: 1.128846452756002
Market cap (USD): 4607951220.150001
Debt to equity: 0.6724644781969623
Current ratio: 2.7673202614379084
Quick ratio: 1.0941176470588236
Effective tax rate (%): 15.238095238095239
Interest coverage ratio: 13.192307692307692
COGS to revenue (%): 29.799426934097422
SG&A to revenue (%): 21.776504297994272
Free cash flow (dilution-adjusted): 382000000
Buyback yield (%): 6.532187204668405
Retained earnings: 5050000000
Inventory turnover: 0.1625
Receivables turnover: 1.4201424211597151
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.06497341996456
FCF margin (%): 27.363896848137536
Revenue growth (%): 4.491017964071856
Rule of 40 score: 31.854914812209394
Financial ratios for BLBD — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 20.86
Shares outstanding: 31646589
Market cap (USD): 660147846.54
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BLBD — annual report dated 2022-09-30
Total revenue: 800637000
Gross profit: 36546000
Operating income: -40700000
Net income: -45759000
Capital expenditures: 6453000
Operating cash flow: -24437000
Depreciation & amortization: 14050000
Net tangible assets: -64876000
Owner earnings: -38162000
Buffett classification: The Gruesome
Stock price: 8.35
Shares outstanding: 31646589
Book value: 1382000
P/B ratio: 191.20768317655572
Market cap (USD): 264249018.14999998
Debt to equity: 124.69609261939219
Current ratio: 1.0588806486460243
Quick ratio: 0.19116486824377632
Interest coverage ratio: -2.7734241908006814
COGS to revenue (%): 95.43538457503213
SG&A to revenue (%): 9.648067726073114
Free cash flow (dilution-adjusted): -34580000
Buyback yield (%): 0.6463600175159252
Retained earnings: -79512000
Inventory turnover: 5.3441532554187035
Receivables turnover: 63.87721397797989
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -20.21335770193492
FCF margin (%): -4.319060947720377
Rule of 40 score: -4.319060947720377
Financial ratios for BLBD — annual report dated 2023-09-30
Total revenue: 1132793000
Gross profit: 138850000
Operating income: 51657000
Net income: 23812000
Capital expenditures: 8520000
Operating cash flow: 119928000
Depreciation & amortization: 15978000
Net tangible assets: -24251000
Owner earnings: 31270000
Return on net tangible assets (%): -128.9431363655107
Capex to operating income (%): 16.493408444160522
Buffett classification: The Great
Stock price: 21.35
P/E ratio: 28.374545403578033
Shares outstanding: 31646589
Book value: 39998000
P/B ratio: 16.892211489324467
Market cap (USD): 675654675.1500001
Debt to equity: 3.2980149007450374
Current ratio: 1.0280594024910723
Quick ratio: 0.4388859855413291
Effective tax rate (%): 34.69482658399535
Interest coverage ratio: 2.867921385742838
COGS to revenue (%): 87.74268555684931
SG&A to revenue (%): 7.697169738866677
Free cash flow (dilution-adjusted): 107235000
Buyback yield (%): 0.0556497296368926
Retained earnings: -55700000
Inventory turnover: 7.346976035953461
Receivables turnover: 90.09010656911086
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 27.455805597780447
FCF margin (%): 9.466425022047275
Revenue growth (%): 41.486466401128105
Rule of 40 score: 50.95289142317538
Financial ratios for BLBD — annual report dated 2024-09-30
Total revenue: 1347154000
Gross profit: 256156000
Operating income: 139331000
Net income: 105547000
Capital expenditures: 15263000
Operating cash flow: 111112000
Depreciation & amortization: 14820000
Net tangible assets: 97185000
Owner earnings: 105104000
Return on net tangible assets (%): 108.14837680712044
Capex to operating income (%): 10.954489668487271
Buffett classification: The Great
Stock price: 47.96
P/E ratio: 14.38004309397709
Shares outstanding: 31646589
Book value: 159564000
P/B ratio: 9.511985212453938
Market cap (USD): 1517770408.44
Debt to equity: 0.601482790604397
Current ratio: 1.3704067838269633
Quick ratio: 0.8288278743754582
Effective tax rate (%): 26.176971072036302
Interest coverage ratio: 13.170526514793458
COGS to revenue (%): 80.98539587901607
SG&A to revenue (%): 8.671985533947863
Free cash flow (dilution-adjusted): 87240000
Buyback yield (%): 0.7323900860226472
Retained earnings: 0
Inventory turnover: 8.536894161097983
Receivables turnover: 22.79486962554358
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 48.22460118856019
FCF margin (%): 6.475874324687453
Revenue growth (%): 18.923227809493877
Rule of 40 score: 25.39910213418133
Financial ratios for BLBD — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 47.96
Shares outstanding: 31646589
Market cap (USD): 1517770408.44
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BLBD — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 38.63
Shares outstanding: 31646589
Market cap (USD): 1222507733.0700002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BLBD — quarterly report dated 2025-03-31
Total revenue: 358851000
Gross profit: 70854000
Operating income: 33711000
Net income: 26046000
Capital expenditures: 9022000
Operating cash flow: 27770000
Depreciation & amortization: 3854000
Net tangible assets: 128947000
Owner earnings: 20878000
Return on net tangible assets (%): 16.191148301240045
Capex to operating income (%): 26.762777728337934
Buffett classification: The Good
Stock price: 32.37
P/E ratio: 9.832604679509329
Shares outstanding: 31646589
Book value: 190392000
P/B ratio: 5.380478622683725
Market cap (USD): 1024400085.93
Debt to equity: 0.48866549014664484
Current ratio: 1.4490394712459078
Quick ratio: 0.7261853286623192
Effective tax rate (%): 27.169642857142858
Interest coverage ratio: 18.59404302261445
COGS to revenue (%): 80.25531487999199
SG&A to revenue (%): 10.350535459006663
Free cash flow (dilution-adjusted): 11314000
Buyback yield (%): 2.2436546341299857
Retained earnings: 24715000
Inventory turnover: 1.7578800234386445
Receivables turnover: 22.732231090839985
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.63264070247152
FCF margin (%): 3.1528405940069835
Rule of 40 score: 3.1528405940069835
Financial ratios for BLBD — quarterly report dated 2025-06-30
Total revenue: 398011000
Gross profit: 85928000
Operating income: 50069000
Net income: 36455000
Capital expenditures: 4599000
Operating cash flow: 56916000
Depreciation & amortization: 3961000
Net tangible assets: 160870000
Owner earnings: 35817000
Return on net tangible assets (%): 22.26456144713122
Capex to operating income (%): 9.185324252531506
Buffett classification: The Great
Stock price: 43.16
P/E ratio: 21.853518843538502
Shares outstanding: 31646589
Book value: 221847000
P/B ratio: 6.1567962660752675
Market cap (USD): 1365866781.24
Debt to equity: 0.41241486249532333
Current ratio: 1.577892107323945
Quick ratio: 0.9171052458887299
Effective tax rate (%): 25.13506926107974
Interest coverage ratio: 28.808400460299193
COGS to revenue (%): 78.4106469419187
SG&A to revenue (%): 9.009549987311908
Free cash flow (dilution-adjusted): 49347000
Buyback yield (%): 0.33151110065721506
Retained earnings: 52230000
Inventory turnover: 2.066200129765231
Receivables turnover: 18.855931400416903
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.434472757884054
FCF margin (%): 12.398401049217233
Revenue growth (%): 10.91260718236817
Rule of 40 score: 23.311008231585404
Financial ratios for BLBD — annual report dated 2025-09-30
Total revenue: 1480099000
Gross profit: 303513000
Operating income: 167166000
Net income: 127720000
Capital expenditures: 22872000
Operating cash flow: 176214000
Depreciation & amortization: 15586000
Net tangible assets: 194905000
Owner earnings: 120434000
Return on net tangible assets (%): 61.79112901156974
Capex to operating income (%): 13.682208104518862
Buffett classification: The Great
Stock price: 57.55
P/E ratio: 14.259796405809583
Shares outstanding: 31646589
Book value: 255415000
P/B ratio: 7.13059607677701
Market cap (USD): 1821261196.9499998
Debt to equity: 0.3536362390619188
Current ratio: 1.7383012597181575
Quick ratio: 1.1493207319287666
Effective tax rate (%): 25.90526290957986
Interest coverage ratio: 23.211052485420716
COGS to revenue (%): 79.49373656762148
SG&A to revenue (%): 9.212018925761047
Free cash flow (dilution-adjusted): 138557000
Buyback yield (%): 2.7132846229170853
Retained earnings: 88193000
Inventory turnover: 8.436122463612246
Receivables turnover: 71.67549636803874
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 43.033445229318126
FCF margin (%): 9.361333262166923
Revenue growth (%): 9.868582211090937
Rule of 40 score: 19.22991547325786
Financial ratios for BLBD — quarterly report dated 2025-09-30
Total revenue: 453836000
Gross profit: 86414000
Operating income: 50344000
Net income: 36497000
Capital expenditures: 4657000
Operating cash flow: 65118000
Depreciation & amortization: 3915000
Net tangible assets: 194905000
Owner earnings: 35755000
Return on net tangible assets (%): 18.344834663040967
Capex to operating income (%): 9.250357540123948
Buffett classification: The Great
Stock price: 57.55
P/E ratio: 18.396949402513183
Shares outstanding: 31646589
Book value: 255415000
P/B ratio: 7.13059607677701
Market cap (USD): 1821261196.9499998
Debt to equity: 0.3536362390619188
Current ratio: 1.7383012597181575
Quick ratio: 1.1493207319287666
Effective tax rate (%): 26.85694164596334
Interest coverage ratio: 29
COGS to revenue (%): 71.160286975912
SG&A to revenue (%): 7.947804933940896
Free cash flow (dilution-adjusted): 58586000
Buyback yield (%): 0.572295726579747
Retained earnings: 88193000
Inventory turnover: 2.31555890155589
Receivables turnover: 21.977530266343827
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.960026360771876
FCF margin (%): 12.909068474074333
Revenue growth (%): 14.02599425644015
Rule of 40 score: 26.93506273051448
Financial ratios for BLBD — quarterly report dated 2025-12-31
Total revenue: 333084000
Gross profit: 71229000
Operating income: 37677000
Net income: 30756000
Capital expenditures: 5465000
Operating cash flow: 36579000
Depreciation & amortization: 3978000
Net tangible assets: 211325000
Owner earnings: 29269000
Return on net tangible assets (%): 13.850230687329942
Capex to operating income (%): 14.5048703453035
Buffett classification: The Great
Stock price: 47
P/E ratio: 11.463150908642508
Shares outstanding: 31646589
Book value: 271368000
P/B ratio: 5.4810798730874675
Market cap (USD): 1487389683
Debt to equity: 0.3285354205359512
Current ratio: 1.8109342701838258
Quick ratio: 1.2115441870752062
Effective tax rate (%): 24.07275415115757
Interest coverage ratio: 24.059386973180075
COGS to revenue (%): 78.61530424757719
SG&A to revenue (%): 10.073134704759159
Free cash flow (dilution-adjusted): 28758000
Buyback yield (%): 1.1654645852481686
Retained earnings: 103990000
Inventory turnover: 1.8581160191591273
Receivables turnover: 30.932763744427934
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.252065182158397
FCF margin (%): 8.633858125878156
Revenue growth (%): -26.606968155897725
Rule of 40 score: -17.97311003001957
Financial ratios for BREE.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.05459459459459459
Shares outstanding: 347090897
Market cap (USD): 18949286.80918919
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BREE.L — annual report dated 2022-12-31
Total revenue: 1682289156.626506
Gross profit: 1385662650.6024096
Operating income: 177831325.30120483
Net income: 135662650.60240963
Capital expenditures: 122891566.26506025
Operating cash flow: 202409638.5542169
Depreciation & amortization: 106385542.1686747
Net tangible assets: 632891566.2650603
Owner earnings: 119156626.50602409
Return on net tangible assets (%): 18.827336759946693
Capex to operating income (%): 69.10569105691057
Buffett classification: The Good
Stock price: 0.03204819277108434
P/E ratio: 0.0819948300195382
Shares outstanding: 347090897
Book value: 1257590361.4457834
P/B ratio: 0.008845198179919524
Market cap (USD): 11123635.976144578
Debt to equity: 0.2868365587277256
Current ratio: 1.4580259922725678
Quick ratio: 1.125043905865824
Effective tax rate (%): 17.083946980854197
Interest coverage ratio: 13.061946902654867
COGS to revenue (%): 17.632313972641985
SG&A to revenue (%): 23.970493446966984
Free cash flow (dilution-adjusted): 72289156.62650603
Buyback yield (%): 0
Retained earnings: 587951807.2289157
Inventory turnover: 2.59704641350211
Receivables turnover: 6.387465690759377
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.832789287855572
FCF margin (%): 4.297070830050849
Rule of 40 score: 4.297070830050849
Financial ratios for BREE.L — annual report dated 2023-12-31
Total revenue: 1882911392.4050632
Gross profit: 1549873417.721519
Operating income: 185063291.1392405
Net income: 133670886.07594936
Capital expenditures: 130886075.94936708
Operating cash flow: 242911392.40506327
Depreciation & amortization: 119873417.72151898
Net tangible assets: 747088607.5949367
Owner earnings: 122658227.84810126
Return on net tangible assets (%): 16.418163334462893
Capex to operating income (%): 70.7250341997264
Buffett classification: The Good
Stock price: 0.04126582278481012
P/E ratio: 0.10715116706628787
Shares outstanding: 347090897
Book value: 1405949367.0886075
P/B ratio: 0.01018741626199694
Market cap (USD): 14322991.445822783
Debt to equity: 0.26721887098226343
Current ratio: 1.6065629228687415
Quick ratio: 1.2002706359945872
Effective tax rate (%): 21.428571428571427
Interest coverage ratio: 11.421875
COGS to revenue (%): 17.687394957983194
Free cash flow (dilution-adjusted): 103924050.63291138
Buyback yield (%): 0
Retained earnings: 1303797468.3544304
Inventory turnover: 2.19067443796836
Receivables turnover: 6.526985519964896
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.269591681460817
FCF margin (%): 5.519327731092437
Revenue growth (%): 11.925550074926761
Rule of 40 score: 17.4448778060192
Financial ratios for BREE.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 604875000
Buffett classification: The Gruesome
Stock price: 0.051875
Shares outstanding: 347090897
Book value: 1463250000
P/B ratio: 0.012305033508884334
Market cap (USD): 18005340.281875
Debt to equity: 0.40603109516487274
Current ratio: 1.2883874518436984
Quick ratio: 0.9149697303247111
Buyback yield (%): 0
Retained earnings: 1351875000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BREE.L — annual report dated 2024-12-31
Total revenue: 1970375000
Gross profit: 1586875000
Operating income: 194875000
Net income: 120375000
Capital expenditures: 157000000
Operating cash flow: 252125000
Depreciation & amortization: 140250000
Net tangible assets: 604875000
Owner earnings: 103625000
Return on net tangible assets (%): 17.131638768340565
Capex to operating income (%): 80.56446440025657
Buffett classification: The Gruesome
Stock price: 0.051875
P/E ratio: 0.14957707399273104
Shares outstanding: 347090897
Book value: 1463250000
P/B ratio: 0.012305033508884334
Market cap (USD): 18005340.281875
Debt to equity: 0.40603109516487274
Current ratio: 1.2883874518436984
Quick ratio: 0.9149697303247111
Effective tax rate (%): 23.205741626794257
Interest coverage ratio: 6.363265306122449
COGS to revenue (%): 19.46330013322337
Free cash flow (dilution-adjusted): 83875000
Buyback yield (%): 0
Retained earnings: 1351875000
Inventory turnover: 2.260869565217391
Receivables turnover: 6.039463601532567
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.701233465423899
FCF margin (%): 4.256803907885555
Revenue growth (%): 4.645126050420176
Rule of 40 score: 8.90192995830573
Financial ratios for BREE.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 478219178.08219177
Buffett classification: The Gruesome
Stock price: 0.05041095890410959
Shares outstanding: 347090897
Book value: 1574520547.9452057
P/B ratio: 0.011112706637898031
Market cap (USD): 17497184.944657534
Debt to equity: 0.5819558030276666
Current ratio: 1.4658736901727556
Quick ratio: 1.0594732370433306
Buyback yield (%): 0
Retained earnings: 1473972602.739726
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRK.L — annual report dated 2021-06-30
Total revenue: 164175000
Operating income: 30825000
Net income: 27280555.555555556
Capital expenditures: 861111.1111111111
Depreciation & amortization: 3693055.5555555555
Owner earnings: 30112500
Capex to operating income (%): 2.793547805713256
Buffett classification: The Great
Stock price: 0.25875
P/E ratio: 0.14652407740046838
Shares outstanding: 15448341
Market cap (USD): 3997258.2337499997
Interest coverage ratio: 69.57366771159874
COGS to revenue (%): 81.2243033348561
SG&A to revenue (%): 81.2243033348561
Free cash flow (dilution-adjusted): 33931944.44444445
Buyback yield (%): 181.02686111231307
Capitalized R&D asset: 0
FCF margin (%): 20.66815559277871
Rule of 40 score: 20.66815559277871
Financial ratios for BRK.L — annual report dated 2022-06-30
Total revenue: 149036585.36585367
Gross profit: 32831707.317073174
Operating income: 32831707.317073174
Net income: 28550000
Capital expenditures: 352439.0243902439
Operating cash flow: 37243902.43902439
Depreciation & amortization: 11504878.048780488
Net tangible assets: 76265853.65853658
Owner earnings: 39702439.02439024
Return on net tangible assets (%): 52.057948767149576
Capex to operating income (%): 1.073471510288983
Buffett classification: The Great
Stock price: 0.2276829268292683
P/E ratio: 0.12319872131476657
Shares outstanding: 15448341
Book value: 181006097.5609756
P/B ratio: 0.019432071852450734
Market cap (USD): 3517323.4935365855
Debt to equity: 0.04060636685194543
Current ratio: 3.3313543465745536
Quick ratio: 3.3313543465745536
Effective tax rate (%): 20.764232044946862
Interest coverage ratio: 95.46808510638299
COGS to revenue (%): 77.97070616152524
SG&A to revenue (%): 77.97070616152524
Free cash flow (dilution-adjusted): 29951219.512195125
Buyback yield (%): 107.48194790229142
Retained earnings: 72146341.46341464
Receivables turnover: 33.11924119241193
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.001256686011633
FCF margin (%): 20.09655511005646
Revenue growth (%): -9.220901254238669
Rule of 40 score: 10.875653855817792
Financial ratios for BRK.L — annual report dated 2023-06-30
Total revenue: 156679746.83544302
Gross profit: 27303797.46835443
Operating income: 27303797.46835443
Net income: 22973417.721518986
Capital expenditures: 943037.9746835442
Operating cash flow: 31593670.886075947
Depreciation & amortization: 12001265.82278481
Net tangible assets: 71850632.9113924
Owner earnings: 34031645.56962025
Return on net tangible assets (%): 47.364433952292025
Capex to operating income (%): 3.4538711172925356
Buffett classification: The Great
Stock price: 0.23784810126582276
P/E ratio: 0.1599395709901372
Shares outstanding: 15448341
Book value: 199169620.25316456
P/B ratio: 0.0184483887145363
Market cap (USD): 3674358.5745569617
Debt to equity: 0.032673632296115515
Current ratio: 3.1791396368644222
Quick ratio: 3.1791396368644222
Effective tax rate (%): 18.39111470839516
Interest coverage ratio: 91.7872340425532
COGS to revenue (%): 82.57349911534455
Free cash flow (dilution-adjusted): 23511392.40506329
Buyback yield (%): 0
Retained earnings: 95136708.8607595
Receivables turnover: 3.6902092898455665
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.86509247717147
FCF margin (%): 15.0060188888081
Revenue growth (%): 5.128379351168701
Rule of 40 score: 20.1343982399768
Financial ratios for BRK.L — annual report dated 2024-06-30
Total revenue: 135040506.32911393
Gross profit: 28067088.607594937
Operating income: 28067088.607594937
Net income: 8173417.721518987
Capital expenditures: 105063.29113924051
Operating cash flow: 44215189.87341772
Depreciation & amortization: 8746835.443037974
Net tangible assets: 87482278.48101266
Owner earnings: 16815189.87341772
Return on net tangible assets (%): 19.221252767287407
Capex to operating income (%): 0.3743291390429802
Buffett classification: The Great
Stock price: 0.22392405063291138
P/E ratio: 0.42323238700634963
Shares outstanding: 15448341
Book value: 192829113.92405063
P/B ratio: 0.017939485495125872
Market cap (USD): 3459255.0922784805
Debt to equity: 0.025036925197754946
Current ratio: 2.2898746206431437
Quick ratio: 2.2898746206431437
Effective tax rate (%): 17.20901889092017
Interest coverage ratio: 144.921568627451
COGS to revenue (%): 79.21580022871711
Free cash flow (dilution-adjusted): 40186075.94936709
Buyback yield (%): 0
Retained earnings: 87143037.97468354
Receivables turnover: 36.79958606416006
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.82882517665696
FCF margin (%): 29.75853471063535
Revenue growth (%): -13.811128077106394
Rule of 40 score: 15.947406633528955
Financial ratios for BRK.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 99238750
Buffett classification: The Gruesome
Stock price: 0.19512499999999997
Shares outstanding: 15448341
Book value: 195798750
P/B ratio: 0.015395182745676363
Market cap (USD): 3014357.5376249994
Debt to equity: 0.019337457465892913
Current ratio: 2.818105616093881
Quick ratio: 2.818105616093881
Buyback yield (%): 0
Retained earnings: 80615000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRK.L — annual report dated 2025-06-30
Total revenue: 152821917.8082192
Gross profit: 16819178.08219178
Operating income: 16819178.08219178
Net income: 28745205.479452055
Capital expenditures: 2536986.301369863
Operating cash flow: 33884931.50684932
Depreciation & amortization: 14265753.424657535
Net tangible assets: 47923287.67123288
Owner earnings: 40473972.60273973
Return on net tangible assets (%): 84.45575120054882
Capex to operating income (%): 15.083889884345986
Buffett classification: The Great
Stock price: 0.22232876712328767
P/E ratio: 0.11948464278974456
Shares outstanding: 15448341
Book value: 211573972.6027397
P/B ratio: 0.01623361591399103
Market cap (USD): 3434610.608630137
Debt to equity: 0.09658851789263771
Current ratio: 1.2460031363923343
Quick ratio: 1.2460031363923343
Effective tax rate (%): 33.614932359152924
Interest coverage ratio: 100.63934426229507
COGS to revenue (%): 88.99426317676586
Free cash flow (dilution-adjusted): 19197260.273972604
Buyback yield (%): 278.03195635914625
Retained earnings: 96034246.57534246
Receivables turnover: 134.08653846153848
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.7619068599374375
FCF margin (%): 12.561850125493008
Revenue growth (%): 13.16746505361088
Rule of 40 score: 25.729315179103885
Financial ratios for BRK.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 47923287.67123288
Buffett classification: The Gruesome
Stock price: 0.22232876712328767
Shares outstanding: 15448341
Book value: 211573972.6027397
P/B ratio: 0.01623361591399103
Market cap (USD): 3434610.608630137
Debt to equity: 0.09658851789263771
Current ratio: 1.2460031363923343
Quick ratio: 1.2460031363923343
Buyback yield (%): 0
Retained earnings: 96034246.57534246
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CIRSA.MC — quarterly report dated 2025-09-30
Total revenue: 740487058.8235295
Gross profit: 548603529.4117647
Operating income: 88035294.11764707
Net income: -6262352.94117647
Capital expenditures: 0
Depreciation & amortization: 115488235.29411764
Net tangible assets: -2098188235.2941177
Owner earnings: 109225882.35294117
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 17.63529411764706
P/E ratio: 93.61099652107507
Shares outstanding: 167877892
Book value: 898005882.352941
P/B ratio: 3.2968336393446926
Market cap (USD): 2960576001.2705884
Debt to equity: 2.799892572431728
Current ratio: 0.9341182423410466
Quick ratio: 0.9085985485586316
Effective tax rate (%): 124.69954990487679
COGS to revenue (%): 25.91315096264144
Buyback yield (%): 0
Retained earnings: -111552941.1764706
Inventory turnover: 9.98109050853681
Receivables turnover: 3.5028354861509183
Capitalized R&D asset: 17478.260869565216
ROCI (R&D-adjusted, %): 2.4151269127426027
Rosenberg metric: 4702.676960784315
Revenue growth (%): 18.12171540392055
Rule of 40 score: 18.12171540392055
Financial ratios for CIRSA.MC — annual report dated 2025-12-31
Total revenue: 2752048235.294118
Gross profit: 1528198823.5294118
Operating income: 523264705.88235295
Net income: 138315294.11764705
Capital expenditures: 103354117.64705883
Operating cash flow: 813612941.1764706
Depreciation & amortization: 423977647.0588235
Net tangible assets: -2181395294.117647
Owner earnings: 458938823.5294117
Return on net tangible assets (%): -21.038773887840804
Capex to operating income (%): 19.751784610196168
Buffett classification: The Great
Stock price: 16.823529411764707
P/E ratio: 20.419279528443116
Shares outstanding: 167877892
Book value: 962328235.2941175
P/B ratio: 2.9348600093645443
Market cap (USD): 2824298653.647059
Debt to equity: 2.6880861244604084
Current ratio: 0.8885691351411638
Quick ratio: 0.8683241151050659
Effective tax rate (%): 36.77576174752895
Interest coverage ratio: 1.9911137971170203
COGS to revenue (%): 44.470492779495565
R&D to revenue (%): 0.005514609225812987
SG&A to revenue (%): 10.935213601334791
Free cash flow (dilution-adjusted): 560756470.5882353
Buyback yield (%): 0
Retained earnings: -62361176.47058824
Inventory turnover: 80.7163252638113
Receivables turnover: 56.45704011198533
Capitalized R&D asset: 226937.6225490196
ROCI (R&D-adjusted, %): 13.785552115676571
Rosenberg metric: 2838.7620493358636
FCF margin (%): 20.37596810247426
Revenue growth (%): 22.87203824998375
Rule of 40 score: 43.248006352458006
Financial ratios for CIRSA.MC — quarterly report dated 2025-12-31
Total revenue: 552194117.6470588
Gross profit: -86688235.29411764
Operating income: 238490588.23529413
Net income: 95182352.94117647
Capital expenditures: 103251411.76470588
Operating cash flow: 813098941.1764706
Depreciation & amortization: 418964705.88235295
Net tangible assets: -2181395294.117647
Owner earnings: 410895647.0588235
Return on net tangible assets (%): -18.8363680882069
Capex to operating income (%): 43.29370501733944
Buffett classification: The Good
Stock price: 16.823529411764707
P/E ratio: 22.272116544541422
Shares outstanding: 167877892
Book value: 962328235.2941175
P/B ratio: 2.9348600093645443
Market cap (USD): 2824298653.647059
Debt to equity: 2.6880861244604084
Current ratio: 0.8885691351411638
Quick ratio: 0.8683241151050659
Effective tax rate (%): 20.126171130702627
COGS to revenue (%): 115.69886974955526
Free cash flow (dilution-adjusted): 560415411.7647059
Buyback yield (%): 0
Retained earnings: -62361176.47058824
Inventory turnover: 42.13609559279951
Receivables turnover: 11.328015639330019
Capitalized R&D asset: 8608.695652173912
ROCI (R&D-adjusted, %): 6.2825296524921095
FCF margin (%): 101.48884130687206
Revenue growth (%): -25.428255488438456
Rule of 40 score: 76.06058581843361
Financial ratios for CMPR — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 108.41
Shares outstanding: 24232090
Market cap (USD): 2627000876.9
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMPR — annual report dated 2022-06-30
Total revenue: 3007869791.666667
Gross profit: 1452946875
Operating income: 63438541.66666667
Net income: -52677083.333333336
Capital expenditures: 56291666.66666667
Operating cash flow: 228683333.33333334
Depreciation & amortization: 183001041.6666667
Net tangible assets: -1569506250
Owner earnings: 74032291.66666667
Capex to operating income (%): 88.73417513669727
Buffett classification: The Gruesome
Stock price: 38.9
Shares outstanding: 24232090
Book value: -378582291.6666665
Market cap (USD): 942628301
Debt to equity: -4.932082137580174
Current ratio: 0.9043750604659088
Quick ratio: 0.7213846440417073
Effective tax rate (%): 641.9569178008787
Interest coverage ratio: 0.6125012571658454
COGS to revenue (%): 51.69515385854122
R&D to revenue (%): 10.141625008008505
SG&A to revenue (%): 34.16682972272389
Free cash flow (dilution-adjusted): 52534375.00000001
Buyback yield (%): 0
Retained earnings: 431393750
Inventory turnover: 11.778975443469477
Receivables turnover: 45.19926430304454
Capitalized R&D asset: 305046875
ROCI (R&D-adjusted, %): 14.487227782246157
FCF margin (%): 1.7465641347091225
Rule of 40 score: 1.7465641347091225
Financial ratios for CMPR — annual report dated 2023-06-30
Total revenue: 3347420652.173913
Gross profit: 1564132608.695652
Operating income: 115951086.95652173
Net income: -201864130.4347826
Capital expenditures: 58447826.086956516
Operating cash flow: 141618478.26086956
Depreciation & amortization: 176552173.91304347
Net tangible assets: -1749127173.9130435
Owner earnings: -83759782.60869564
Capex to operating income (%): 50.40731192875556
Buffett classification: The Good
Stock price: 59.48
Shares outstanding: 24232090
Book value: -664992391.3043478
Market cap (USD): 1441324713.1999998
Debt to equity: -2.8717932372550847
Current ratio: 0.683411019444255
Quick ratio: 0.5163109841136035
Interest coverage ratio: 0.9457590453308272
COGS to revenue (%): 53.27349708260123
R&D to revenue (%): 9.814727562786011
SG&A to revenue (%): 31.926463821755036
Free cash flow (dilution-adjusted): -25426086.956521735
Buyback yield (%): 0
Retained earnings: 255865217.39130434
Inventory turnover: 15.214216163583252
Receivables turnover: 45.72367971731029
Capitalized R&D asset: 532921623.6413043
ROCI (R&D-adjusted, %): 12.626784194120628
Rosenberg metric: 0.3644873716396931
FCF margin (%): -0.7595725066704506
Revenue growth (%): 11.288748650223326
Rule of 40 score: 10.529176143552876
Financial ratios for CMPR — annual report dated 2024-06-30
Total revenue: 3539630107.5268817
Gross profit: 1716982795.6989245
Operating income: 266423655.9139785
Net income: 191191397.84946236
Capital expenditures: 59061290.32258064
Operating cash flow: 377120430.10752684
Depreciation & amortization: 163187096.77419353
Net tangible assets: -1619415053.7634408
Owner earnings: 295317204.3010753
Return on net tangible assets (%): -18.23604168769289
Capex to operating income (%): 22.16818552390485
Buffett classification: The Great
Stock price: 87.61
P/E ratio: 11.10391695850018
Shares outstanding: 24232090
Book value: -566144086.0215051
Market cap (USD): 2122973404.9
Debt to equity: -3.2709177723669276
Current ratio: 0.6897658453859629
Quick ratio: 0.5436492696129153
Effective tax rate (%): -38.43015742023886
Interest coverage ratio: 2.0678506451236003
COGS to revenue (%): 51.49259262859614
R&D to revenue (%): 9.780743750637937
SG&A to revenue (%): 30.244609727764516
Free cash flow (dilution-adjusted): 184843010.75268817
Buyback yield (%): 7.951011024102611
Retained earnings: 293420430.10752684
Inventory turnover: 17.47198400263874
Receivables turnover: 50.97646184340932
Capitalized R&D asset: 666989564.9398082
ROCI (R&D-adjusted, %): 14.390487184886192
Rosenberg metric: 0.4652404147563522
FCF margin (%): 5.222099630117478
Revenue growth (%): 5.742016774262961
Rule of 40 score: 10.964116404380439
Financial ratios for CMPR — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 81.92
Shares outstanding: 24232090
Market cap (USD): 1985092812.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMPR — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 71.72
Shares outstanding: 24232090
Market cap (USD): 1737925494.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMPR — quarterly report dated 2025-03-31
Total revenue: 858117391.3043478
Gross profit: 404900000
Operating income: 44572826.08695652
Net income: -8717391.304347826
Capital expenditures: 26947826.08695652
Operating cash flow: 10538043.47826087
Depreciation & amortization: 37282608.69565217
Net tangible assets: -1639517391.3043478
Owner earnings: 1617391.3043478243
Capex to operating income (%): 60.457970590387
Buffett classification: The Good
Stock price: 45.23
Shares outstanding: 24232090
Book value: -583377173.9130435
Market cap (USD): 1096017430.6999998
Debt to equity: -3.1703350245105804
Current ratio: 0.6528007862269054
Quick ratio: 0.502888030342709
Effective tax rate (%): 294.4713870029098
Interest coverage ratio: 1.5190590850157437
COGS to revenue (%): 52.815313603591285
R&D to revenue (%): 10.52759579868975
SG&A to revenue (%): 30.889789073147995
Free cash flow (dilution-adjusted): -47960869.56521739
Buyback yield (%): 0.3914369672537315
Retained earnings: 289325000
Inventory turnover: 4.0920153882389885
Receivables turnover: 11.935234178937502
Capitalized R&D asset: 90339130.43478261
ROCI (R&D-adjusted, %): 7.5222785525143445
FCF margin (%): -5.589080241377738
Rule of 40 score: -5.589080241377738
Financial ratios for CMPR — annual report dated 2025-06-30
Total revenue: 4003622352.9411764
Gross profit: 1902875294.1176472
Operating income: 272703529.41176474
Net income: 17590588.23529412
Capital expenditures: 104734117.64705883
Operating cash flow: 350670588.2352941
Depreciation & amortization: 166036470.5882353
Net tangible assets: -1850303529.4117649
Owner earnings: 78892941.1764706
Return on net tangible assets (%): -4.263783748040066
Capex to operating income (%): 38.40585337233281
Buffett classification: The Good
Stock price: 47
P/E ratio: 64.74531805109685
Shares outstanding: 24232090
Book value: -662877647.0588236
Market cap (USD): 1138908230
Debt to equity: -3.0298289454535126
Current ratio: 0.6624900153164386
Quick ratio: 0.5137149349776317
Effective tax rate (%): 86.74491279819306
Interest coverage ratio: 2.0115941022815043
COGS to revenue (%): 52.471159206118934
R&D to revenue (%): 9.81566986837508
SG&A to revenue (%): 30.341611229125153
Free cash flow (dilution-adjusted): 101263529.41176473
Buyback yield (%): 8.034009904380092
Retained earnings: 264843529.4117647
Inventory turnover: 15.8202799681049
Receivables turnover: 49.8334870916253
Capitalized R&D asset: 733356065.5405219
ROCI (R&D-adjusted, %): 14.36632567663593
Rosenberg metric: 0.5369478442870473
FCF margin (%): 2.529297733023536
Revenue growth (%): 13.108495275470558
Rule of 40 score: 15.637793008494095
Financial ratios for CMPR — quarterly report dated 2025-06-30
Total revenue: 1022921176.4705882
Gross profit: 485647058.8235294
Operating income: 82636470.58823529
Net income: -29785882.352941178
Capital expenditures: 24485882.352941178
Operating cash flow: 126437647.05882353
Depreciation & amortization: 42440000
Net tangible assets: -1850303529.4117649
Owner earnings: -11831764.705882356
Capex to operating income (%): 29.63084238550135
Buffett classification: The Good
Stock price: 47
Shares outstanding: 24232090
Book value: -662877647.0588236
Market cap (USD): 1138908230
Debt to equity: -3.0298289454535126
Current ratio: 0.6624900153164386
Quick ratio: 0.5137149349776317
Effective tax rate (%): 310.72224699063753
Interest coverage ratio: 2.539810529360717
COGS to revenue (%): 52.52351109797432
R&D to revenue (%): 9.9120971887892
SG&A to revenue (%): 28.995161492519117
Free cash flow (dilution-adjusted): 63491764.70588235
Buyback yield (%): 2.1528357494977244
Retained earnings: 264843529.4117647
Inventory turnover: 4.046097280056703
Receivables turnover: 12.732401997393431
Capitalized R&D asset: 161920158.56777495
ROCI (R&D-adjusted, %): 7.579232554037069
Rosenberg metric: 0.8938215193672041
FCF margin (%): 6.2069068630439
Revenue growth (%): 19.205272709336064
Rule of 40 score: 25.412179572379966
Financial ratios for CMPR — quarterly report dated 2025-09-30
Total revenue: 1015620000
Gross profit: 473883529.41176474
Operating income: 57963529.4117647
Net income: 8984705.88235294
Capital expenditures: 31003529.411764707
Operating cash flow: 29481176.470588237
Depreciation & amortization: 43080000
Net tangible assets: -1833164705.882353
Owner earnings: 21061176.470588233
Return on net tangible assets (%): -1.1488971178097662
Capex to operating income (%): 53.48799447928718
Buffett classification: The Good
Stock price: 63.04
P/E ratio: 42.50531329579678
Shares outstanding: 24232090
Book value: -649794117.647059
Market cap (USD): 1527590953.6
Debt to equity: -3.095371384601457
Current ratio: 0.648346770132672
Quick ratio: 0.49003503638801876
Effective tax rate (%): 73.23261351506692
Interest coverage ratio: 1.7554692510510936
COGS to revenue (%): 53.34046893407331
R&D to revenue (%): 9.832996824889346
SG&A to revenue (%): 30.62678607214139
Free cash flow (dilution-adjusted): -39262352.941176474
Buyback yield (%): 0.2099422503106274
Retained earnings: 271415294.11764705
Inventory turnover: 3.8543555231901157
Receivables turnover: 10.964893117069515
Capitalized R&D asset: 197611065.98465472
ROCI (R&D-adjusted, %): 3.7348238556144144
Rosenberg metric: -0.11601921470342498
FCF margin (%): -3.8658507060885445
Revenue growth (%): -0.7137574857702769
Rule of 40 score: -4.579608191858822
Financial ratios for CMPR — quarterly report dated 2025-12-31
Total revenue: 1226120000
Gross profit: 573785882.3529412
Operating income: 105177647.05882353
Net income: 58223529.4117647
Capital expenditures: 29623529.411764707
Operating cash flow: 193718823.52941176
Depreciation & amortization: 43080000
Net tangible assets: -1787055294.1176472
Owner earnings: 71680000
Return on net tangible assets (%): -4.011067829627049
Capex to operating income (%): 28.165233051084442
Buffett classification: The Good
Stock price: 66.59
P/E ratio: 56.21379653856504
Shares outstanding: 24232090
Book value: -616436470.5882354
Market cap (USD): 1613614873.1000001
Debt to equity: -3.3408490164532
Current ratio: 0.6793027726396731
Quick ratio: 0.5307079770286367
Effective tax rate (%): 21.228134400814934
Interest coverage ratio: 3.311516094380857
COGS to revenue (%): 53.20312185161802
R&D to revenue (%): 8.546999526003598
SG&A to revenue (%): 29.395165236681564
Free cash flow (dilution-adjusted): 125442352.94117647
Buyback yield (%): 1.856263329980742
Retained earnings: 306988235.2941176
Inventory turnover: 4.517181262729124
Receivables turnover: 14.761022590468096
Capitalized R&D asset: 205166282.3529412
ROCI (R&D-adjusted, %): 6.360518623426721
Rosenberg metric: 1.0003651956741977
FCF margin (%): 10.230838167648884
Revenue growth (%): 20.72625588310589
Rule of 40 score: 30.957094050754772
Financial ratios for CPI.V — annual report dated 2021-07-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.29032258064516125
Shares outstanding: 88741344
Market cap (USD): 25763615.999999996
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPI.V — annual report dated 2022-07-31
Total revenue: 0
Gross profit: -1215.625
Operating income: -506442.96875
Net income: 3132975.78125
Capital expenditures: 682573.4375
Operating cash flow: -631772.65625
Depreciation & amortization: 1215.625
Net tangible assets: 13528884.375
Owner earnings: 2451617.96875
Return on net tangible assets (%): 18.121360940007296
Buffett classification: The Gruesome
Stock price: 0.05468750000000001
P/E ratio: 1.5490200336191955
Shares outstanding: 88741344
Book value: 13528884.375
P/B ratio: 0.3587171059697966
Market cap (USD): 4853042.250000001
Debt to equity: 0.04239193780529298
Current ratio: 10.385135104148514
Quick ratio: 10.385135104148514
Interest coverage ratio: -12.8172848782031
Free cash flow (dilution-adjusted): -1314346.09375
Buyback yield (%): 0
Retained earnings: -12543313.28125
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.7434200390229884
Rule of 40 score: 0
Financial ratios for CPI.V — annual report dated 2023-07-31
Total revenue: 0
Gross profit: -471.4285714285714
Operating income: -310475.93984962406
Net income: -369799.2481203007
Capital expenditures: 320433.83458646614
Operating cash flow: -296648.8721804511
Depreciation & amortization: 471.4285714285714
Net tangible assets: 9656190.97744361
Owner earnings: -689761.6541353383
Return on net tangible assets (%): -7.143206423180608
Buffett classification: The Gruesome
Stock price: 0.045112781954887216
Shares outstanding: 88741344
Book value: 9656190.977443608
P/B ratio: 0.41459089941440824
Market cap (USD): 4003368.902255639
Debt to equity: 0
Current ratio: 66.23079151850389
Quick ratio: 66.23079151850389
Free cash flow (dilution-adjusted): -617082.7067669173
Buyback yield (%): 0
Retained earnings: -12441559.39849624
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.215304467101787
Rule of 40 score: 0
Financial ratios for CPI.V — annual report dated 2024-07-31
Total revenue: 0
Gross profit: -442.02898550724643
Operating income: -262197.82608695654
Net income: -264694.2028985507
Capital expenditures: 149764.4927536232
Operating cash flow: -41477.53623188406
Depreciation & amortization: 442.02898550724643
Net tangible assets: 8030656.521739131
Owner earnings: -414016.6666666666
Return on net tangible assets (%): -5.155452303879715
Buffett classification: The Gruesome
Stock price: 0.05072463768115943
Shares outstanding: 88741344
Book value: 8030656.521739131
P/B ratio: 0.5605236022178057
Market cap (USD): 4501372.521739132
Debt to equity: 0
Current ratio: 11.118592371408809
Quick ratio: 11.118592371408809
Free cash flow (dilution-adjusted): -191242.02898550726
Buyback yield (%): 0
Retained earnings: -12255472.463768117
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.2649612815238997
Rule of 40 score: 0
Financial ratios for CPI.V — quarterly report dated 2024-10-31
Capital expenditures: 29631.654676258993
Buffett classification: The Gruesome
Stock price: 0.05035971223021583
Shares outstanding: 88741344
Market cap (USD): 4468988.54676259
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0